27 March 2018
With a lack of contract manufacturing organizations (CMOs) operating in the cell and gene therapies sphere, it appears to be heading towards major capacity crunches in both R&D and commercial...
21 December 2017
Novaliq’s NovaTears+Omega-3 represents the first-in-class omega-3-containing eye drop for evaporative dry eye
Novaliq announced NovaTears+Omega-3, the first omega-3-containing eye drop registered in Europe for the enhanced treatment of the signs and symptoms of evaporative dry eye (EDE), early this month.
2 November 2017
On 28 October at the 7th Joint ECTRIMS-ACTRIMS conference held in Paris, MediciNova reported surprisingly good Phase II results for its first-in-class, small-molecule drug ibudilast in progressive types of multiple...
1 November 2017
As mainstream consumer products, probiotics are often thought of as modestly effective at best, and are typically restricted to aiding gastrointestinal function. However, new research points to many more diverse...
18 October 2017
On 11 October, Ardelyx reported positive results from a second pivotal Phase III trial (T3MPO-2) assessing the efficacy and safety of its lead product, tenapanor, which is under development for...
27 September 2017
On September 13, GlaxoSmithKline (GSK) announced that the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously to recommend the approval of its investigational vaccine, Shingrix (zoster vaccine,...
26 September 2017
Among the current unmet needs in prostate cancer, the lack of therapeutic options for non-metastatic castration-resistant prostate cancer (nmCRPC) patients and the need to delay the onset of castration-resistant disease...
30 August 2017
A recent licensing agreement allows Mylan to commercialise Otsuka Novel Products' Delamanid (Deltyba) product indicated for pulmonary multidrug-resistant tuberculosis (MDR-TB) in low and middle-income countries such as India and South...
27 July 2017
A research paper from Dr Hector Deluca’s lab at the University of Wisconsin has reported a possible role for sunscreens in the treatment of multiple sclerosis (MS). The paper was...
26 July 2017
Cases of antibiotic-resistant ‘super gonorrhea’ are rising rapidly according to the World Health Organization (WHO).